Product Information
ZAFEMY 150-35 MCG/DAY PATCH is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $31.9079 per EA under NDC 65162035803. Its NADAC has been published 202 times since Nov 23, 2022.
FDA first approved this application on Feb 25, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
35; 150 ug/d; ug/d
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162035803
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; NORELGESTROMINApproval Type
Generic (ANDA)
FDA Application
ANDA213950FDA Approved
2/25/2021
TE Code
AB
On Market Since
6/28/2020
Price Statistics
The NADAC for ZAFEMY 150-35 MCG/DAY PATCH has been published 202 times since Nov 23, 2022, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $31.9079 per EA |
|---|---|
| All-time high | $36.4868 (Aug 16, 2023) |
| All-time low | $23.6930 (Nov 20, 2024) |
| 52-week high | $32.3819 |
| 52-week low | $28.0133 |
| Median price | $32.1680 |
| Average price | $32.0638 |
| Largest weekly change | -20.6% (Nov 20, 2024) |
| Weeks tracked | 202 |
| Tracking since | Nov 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norelgestromin and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norelgestromin and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZAFEMY 150-35 MCG/DAY PATCH?
The current National Average Drug Acquisition Cost (NADAC) for ZAFEMY 150-35 MCG/DAY PATCH, manufactured by Amneal Pharmaceuticals LLC, is $31.9079 per EA (NDC 65162035803), effective Sep 30, 2026.
How has the price of ZAFEMY 150-35 MCG/DAY PATCH changed over time?
Over the history we have for it, the NADAC for ZAFEMY 150-35 MCG/DAY PATCH has declined 10.9%. It has been tracked across 202 weekly CMS publications since Nov 23, 2022.
What are the highest and lowest recorded NADAC prices for ZAFEMY 150-35 MCG/DAY PATCH?
Since Nov 23, 2022, the NADAC for ZAFEMY 150-35 MCG/DAY PATCH has ranged from a low of $23.6930 (Nov 20, 2024) to a high of $36.4868 (Aug 16, 2023), with a median of $32.1680 per EA.
Are there cheaper alternatives to ZAFEMY 150-35 MCG/DAY PATCH?
No other NADAC-published product currently shares the active ingredient and strength of ZAFEMY 150-35 MCG/DAY PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZAFEMY 150-35 MCG/DAY PATCH?
ZAFEMY 150-35 MCG/DAY PATCH (NDC 65162035803) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.